Erlotinib in the treatment of advanced pancreatic cancer

por Kelley, Robin K, Ko, Andrew H
Publicado 2008

KRAS mutational analysis for colorectal cancer: Application: Pharmacogenomic

por Wang, Grace, Kelley, Robin K., GAPPNet
Publicado 2010

Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response

por Keenan, Bridget P., Fong, Lawrence, Kelley, Robin K.
Publicado 2019

Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review

por Vogel, Arndt, Kelley, Robin K., Johnson, Philip, Merle, Philippe, Yau, Thomas, Kudo, Masatoshi, Meyer, Tim, Rimassa, Lorenza
Publicado 2023

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

por Llovet, Josep M., Pinyol, Roser, Kelley, Robin K., El-Khoueiry, Anthony, Reeves, Helen, Wang, Xin Wei, Gores, Gregory J., Villanueva, Augusto
Publicado 2022

Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma

por Kelley, Robin K., Mollon, Patrick, Blanc, Jean-Frédéric, Daniele, Bruno, Yau, Thomas, Cheng, Ann-Lii, Valcheva, Velichka, Marteau, Florence, Guerra, Ines, Abou-Alfa, Ghassan K.
Publicado 2020

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma

por Harding, James J., Do, Richard K., Yaqubie, Amin, Cleverly, Ann, Zhao, Yumin, Gueorguieva, Ivelina, Lahn, Michael, Benhadji, Karim A., Kelley, Robin K., Abou‐Alfa, Ghassan K.
Publicado 2021

Polyunsaturated Fatty Acid–Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism

por Munson, Paul V., Adamik, Juraj, Hartmann, Felix J., Favaro, Patricia M.B., Ho, Daniel, Bendall, Sean C., Combes, Alexis J., Krummel, Matthew F., Zhang, Karen, Kelley, Robin K., Butterfield, Lisa H.
Publicado 2023

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib

por Giannelli, Gianluigi, Santoro, Armando, Kelley, Robin K., Gane, Ed, Paradis, Valerie, Cleverly, Ann, Smith, Claire, Estrem, Shawn T., Man, Michael, Wang, Shuaicheng, Lahn, Michael M., Raymond, Eric, Benhadji, Karim A., Faivre, Sandrine
Publicado 2020

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib

por Giannelli, Gianluigi, Santoro, Armando, Kelley, Robin K., Gane, Ed, Paradis, Valerie, Cleverly, Ann, Smith, Claire, Estrem, Shawn T., Man, Michael, Wang, Shuaicheng, Lahn, Michael M., Raymond, Eric, Benhadji, Karim A., Faivre, Sandrine
Publicado 2021

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls

por Kelley, Robin K, Magbanua, Mark Jesus M, Butler, Timothy M, Collisson, Eric A, Hwang, Jimmy, Sidiropoulos, Nikoletta, Evason, Kimberley, McWhirter, Ryan M, Hameed, Bilal, Wayne, Elizabeth M, Yao, Francis Y, Venook, Alan P, Park, John W
Publicado 2015

An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intraveno...

por El Dika, Imane, Lim, Ho Yeong, Yong, Wei Peng, Lin, Chia‐Chi, Yoon, Jung‐Hwan, Modiano, Manuel, Freilich, Bradley, Choi, Hye Jin, Chao, Tsu‐Yi, Kelley, Robin K., Brown, Joanne, Knox, Jennifer, Ryoo, Baek‐Yeol, Yau, Thomas, Abou‐Alfa, Ghassan K.
Publicado 2018

What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature

por McNamara, Mairéad G, Bridgewater, John, Goyal, Lipika, Jacobs, Timothy, Wagner, Anna D, Goldstein, David, Shroff, Rachna, Moehler, Markus, Lowery, Maeve, Bekaii-Saab, Tanios, Kelley, Robin K, Furuse, Junji, Rimassa, Lorenza, Morizane, Chigusa, Lamarca, Angela, Hubner, Richard, Knox, Jennifer, Valle, Juan
Publicado 2022

Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis

por Keenan, Bridget P., McCarthy, Elizabeth E., Ilano, Arielle, Yang, Hai, Zhang, Li, Allaire, Kathryn, Fan, Zenghua, Li, Tony, Lee, David S., Sun, Yang, Cheung, Alexander, Luong, Diamond, Chang, Hewitt, Chen, Brandon, Marquez, Jaqueline, Sheldon, Brenna, Kelley, Robin K., Ye, Chun Jimmie, Fong, Lawrence
Publicado 2022

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanc...

por Bendell, Johanna C., Kelley, Robin K., Shih, Kent C., Grabowsky, Jennifer A., Bergsland, Emily, Jones, Suzanne, Martin, Thomas, Infante, Jeffrey R., Mischel, Paul S., Matsutani, Tomoo, Xu, Shuichan, Wong, Lilly, Liu, Yong, Wu, Xiaoling, Mortensen, Deborah S., Chopra, Rajesh, Hege, Kristen, Munster, Pamela N.
Publicado 2015

Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

por Xie, Enrui, Yeo, Yee Hui, Scheiner, Bernhard, Zhang, Yue, Hiraoka, Atsushi, Tantai, Xinxing, Fessas, Petros, de Castro, Tiago, D’Alessio, Antonio, Fulgenzi, Claudia Angela Maria, Xu, Shuo, Tsai, Hong-Ming, Kambhampati, Swetha, Wang, Wenjun, Keenan, Bridget P., Gao, Xu, Xing, Zixuan, Pinter, Matthias, Lin, Yih-Jyh, Guo, Zhanjun, Vogel, Arndt, Tanaka, Takaaki, Kuo, Hsin-Yu, Kelley, Robin K., Kudo, Masatoshi, Yang, Ju Dong, Pinato, David J., Ji, Fanpu
Publicado 2023